Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CARDLYTICS, INC.

(CDLX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 2321 6163 9213 046--
Entreprise Value (EV)1 2391 5123 6282 8232 8452 853
P/E ratio -3,88x-87,3x-70,0x-24,0x-33,4x-39,2x
Yield ------
Capitalization / Revenue 1,54x7,68x21,0x12,0x8,81x6,65x
EV / Revenue 1,59x7,18x19,4x11,1x8,23x6,22x
EV / EBITDA -36,2x250x-466x-192x1 085x75,6x
Price to Book 4,68x11,6x25,3x4,38x4,99x5,34x
Nbr of stocks (in thousands) 21 41225 71227 46433 040--
Reference price (USD) 10,862,914392,292,292,2
Announcement Date 03/05/201903/03/202003/01/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 151210187255346458
EBITDA1 -6,606,05-7,78-14,72,6237,7
Operating profit (EBIT)1 -40,9-17,3-53,9-116-100-
Operating Margin -27,2%-8,23%-28,9%-45,4%-29,0%-
Pre-Tax Profit (EBT)1 -53,0-17,1-55,4-120-91,3-
Net income1 -53,2-17,1-55,4-124-95,7-81,9
Net margin -35,3%-8,15%-29,7%-48,6%-27,7%-17,9%
EPS2 -2,79-0,72-2,04-3,84-2,76-2,35
Dividend per Share2 ------
Announcement Date 03/05/201903/03/202003/01/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 67,153,258,962,180,569,4
EBITDA1 4,49-3,94-5,67-7,412,29-6,80
Operating profit (EBIT)1 -6,12-22,2-42,7-31,1-19,6-27,4
Operating Margin -9,12%-41,6%-72,6%-50,1%-24,3%-39,5%
Pre-Tax Profit (EBT)1 -6,78-24,9-47,3-34,1-22,6-30,4
Net income1 -6,78-24,9-47,3-30,5-17,2-31,6
Net margin -10,1%-46,8%-80,4%-49,1%-21,4%-45,5%
EPS2 -0,24-0,85-1,43-0,95-0,60-0,91
Dividend per Share ------
Announcement Date 03/01/202105/04/202108/03/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 7,09-----
Net Cash position1 -104293224201194
Leverage (Debt / EBITDA) -1,08x-17,3x37,7x15,2x-76,6x-5,13x
Free Cash Flow1 -24,93,18-13,0-31,8-16,614,0
ROE (Net Profit / Equities) --17,6%-15,5%-17,1%-7,32%-3,04%
Shareholders' equity1 -97,63587221 3072 692
ROA (Net Profit / Asset) -11,6%-1,01%-7,19%-6,64%-3,93%-1,52%
Assets1 4591 7067711 8612 4375 402
Book Value Per Share2 2,315,405,6421,118,517,3
Cash Flow per Share2 -1,000,48--6,01-1,37-
Capex1 5,928,285,415,607,9010,0
Capex / Sales 3,93%3,93%2,89%2,20%2,28%2,18%
Announcement Date 03/05/201903/03/202003/01/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 3 046 298 326
Net sales (USD) 186 892 000
Number of employees 605
Sales / Employee (USD) 308 912
Free-Float 94,1%
Free-Float capitalization (USD) 2 867 109 747
Avg. Exchange 20 sessions (USD) 34 093 209
Average Daily Capital Traded 1,12%
EPS & Dividend
Change in Enterprise Value/EBITDA